Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4549313 | 0.86 | PIM1 (0.35) | L3MBTL1CYP11B1PIM1PIM2ALOX5 | |
| SCHEMBL4549349 | 0.82 | ALOX5 (0.45) | MCL1TLR8TLR7L3MBTL1ATM | |
| SCHEMBL8281206 | 0.80 | NPC1 (0.38) | MCL1L3MBTL1KDM4EALDH1A1RAB9A | |
| SCHEMBL10127925 | 0.79 | ATM (0.30) | L3MBTL1ATMRAB9A | |
| SCHEMBL9603912 | 0.79 | NPC1 (0.40) | ATMKDM4EALDH1A1RAB9A | |
| SCHEMBL789800 | 0.78 | PIM1 (0.32) | MCL1PIM1PIM2ALDH1A1 | |
| SCHEMBL4549297 | 0.78 | PIM1 (0.38) | L3MBTL1ATMCYP11B1PIM1PIM2 | |
| SCHEMBL10127371 | 0.78 | POLB (0.39) | MCL1 | |
| SCHEMBL4549310 | 0.77 | DHODH (0.34) | L3MBTL1ATMCYP11B1ALOX5 | |
| SCHEMBL889804 | 0.77 | HPGD (0.41) | MCL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | MCL1 1281/4885TLR8 3869/4885TLR7 1771/4885 |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | MCL1 1281/4885TLR8 3869/4885TLR7 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.